Stay updated on Etrasimod in Atopic Dermatitis: Clinical Trial
Sign up to get notified when there's something new on the Etrasimod in Atopic Dermatitis: Clinical Trial page.

Latest updates to the Etrasimod in Atopic Dermatitis: Clinical Trial page
- Check3 days agoChange DetectedThe record displays details of the completed etrasimod study for moderate-to-severe atopic dermatitis, including its methods, participant criteria, locations, and measured outcomes. It also includes study results-related resources and supporting documents.SummaryDifference72%

- Check10 days agoChange DetectedThe site revision label was updated from v3.7.2 to v3.8.0. The page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.” The site revision advances from v3.7.1 to v3.7.2.SummaryDifference1%

- Check38 days agoChange DetectedThe footer revision identifier was updated from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check52 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, indicating access to the resource is blocked. This renders the study record unavailable to viewers.SummaryDifference19%

- Check59 days agoChange DetectedAtopic dermatitis is now listed as a topic and related topics include MedlinePlus Genetics. The page's revision tag has been updated to v3.7.0, replacing the previous v3.6.6.SummaryDifference0.2%

Stay in the know with updates to Etrasimod in Atopic Dermatitis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Etrasimod in Atopic Dermatitis: Clinical Trial page.